-
公开(公告)号：US11839689B2
公开(公告)日：2023-12-12
申请号：US17985235
申请日：2022-11-11
Applicant: Astellas Pharma Inc. , Medivation Prostate Therapeutics LLC
Inventor： Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
CPC classification number: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：US20230042959A1
公开(公告)日：2023-02-09
申请号：US17959350
申请日：2022-10-04
Applicant: Medivation Prostate Therapeutics LLC , Astellas Pharma Inc.
Inventor： Jacqueline Gibbons , Joyce Mordenti , Michiel De Vries , Walter Krauwinkel , Taoufik Ouatas
IPC: A61K31/4166 , A61K45/06 , A61K31/496 , A61K31/515 , A61K31/55 , A61K31/438 , A61P35/00
Abstract: This disclosure provides a dosage regimen for co-administration of enzalutamide and a strong CYP3A4 inducer.
-
公开(公告)号：US20190209476A1
公开(公告)日：2019-07-11
申请号：US16044255
申请日：2018-07-24
Applicant: Medivation Prostate Therapeutics LLC , Astellas Pharma Inc.
Inventor： Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC: A61K9/20 , C07D233/86 , A61K47/38 , A61K47/32 , A61K31/4166 , A61K9/16 , A61K31/4164 , A61K9/10
CPC classification number: A61K9/2054 , A61K9/10 , A61K9/16 , A61K9/1652 , A61K9/2095 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：US20250090465A1
公开(公告)日：2025-03-20
申请号：US18967829
申请日：2024-12-04
Applicant: Astellas Pharma Inc. , Medivation Prostate Therapeutics LLC
Inventor： Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC: A61K9/20 , A61K9/10 , A61K9/16 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：US12161628B2
公开(公告)日：2024-12-10
申请号：US17959350
申请日：2022-10-04
Applicant: Medivation Prostate Therapeutics LLC , Astellas Pharma Inc.
Inventor： Jacqueline Gibbons , Joyce Mordenti , Michiel De Vries , Walter Krauwinkel , Taoufik Ouatas
IPC: A61K31/4166 , A61K31/438 , A61K31/496 , A61K31/515 , A61K31/55 , A61K45/06 , A61P35/00 , A61K31/435
Abstract: This disclosure provides a dosage regimen for co-administration of enzalutamide and a strong CYP3A4 inducer.
-
Patent Agency Ranking
公开(公告)号：US20230122911A1
公开(公告)日：2023-04-20
申请号：US17985220
申请日：2022-11-11
Applicant: Astellas Pharma Inc. , Medivation Prostate Therapeutics LLC
Inventor： Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC: A61K9/20 , C07D233/86 , A61K9/10 , A61K31/4166 , A61K47/32 , A61K47/38 , A61K9/16 , A61K31/4164
Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：US20250049721A1
公开(公告)日：2025-02-13
申请号：US18931464
申请日：2024-10-30
Applicant: Astellas Pharma Inc. , Medivation Prostate Therapeutics LLC
Inventor： Douglas Alan Lorenz , Sanjay Konagurthu , Randy J. Wald , Jason A. Everett , Sheila Matz , Yuuki Takaishi , Toshiro Sakai , Ryousuke Irie , Shinsuke Oba , Hiroyasu Toyota , Koji Nishimura , Atsushi Kanbayashi
IPC: A61K9/20 , A61K9/10 , A61K9/16 , A61K31/4164 , A61K31/4166 , A61K47/32 , A61K47/38 , C07D233/86
Abstract: This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
-
公开(公告)号：US20190262315A1
公开(公告)日：2019-08-29
申请号：US16168896
申请日：2018-10-24
Applicant: MEDIVATION PROSTATE THERAPEUTICS LLC , THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Inventor： Andrew A. Protter , Jennifer Richer , Dawn Cochrane
IPC: A61K31/4184 , A61K31/4166
Abstract: The disclosure describes compounds useful for treating breast cancers.
-
公开(公告)号：US11952634B2
公开(公告)日：2024-04-09
申请号：US17523235
申请日：2021-11-10
Applicant: Medivation Prostate Therapeutics LLC
Inventor： Amy Christian Peterson , Hirdesh Uppal
IPC: A61K31/4164 , A61K31/337 , A61K31/4166 , A61K45/06 , A61P35/00 , C12Q1/6886
CPC classification number: C12Q1/6886 , A61K31/337 , A61K31/4166 , A61K45/06 , C12Q2600/106 , C12Q2600/112 , C12Q2600/158
Abstract: Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.
-
公开(公告)号：US20210069154A1
公开(公告)日：2021-03-11
申请号：US16749133
申请日：2020-01-22
Applicant: MEDIVATION PROSTATE THERAPEUTICS LLC , THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Inventor： Andrew A. Protter , Jennifer Richer , Dawn Cochrane
IPC: A61K31/4184 , A61K31/4166
Abstract: The disclosure describes compounds useful for treating breast cancers.
-
-
-
-
-
-
-
-
-
Search Results
19
records
(took 0.016 seconds)
